Chemical Synthesis of Monomeric, Dimeric and Tetrameric Forms of the Ectodomain of Influenza Matrix 2 Protein
暂无分享,去创建一个
[1] D. Jackson,et al. A lipidated form of the extracellular domain of influenza M2 protein as a self-adjuvanting vaccine candidate. , 2015, Vaccine.
[2] D. Jackson,et al. A totally synthetic lipopeptide-based self-adjuvanting vaccine induces neutralizing antibodies against heat-stable enterotoxin from enterotoxigenic Escherichia coli. , 2012, Vaccine.
[3] J. Katz,et al. Development and evaluation of an M2-293FT cell-based flow cytometric assay for quantification of antibody response to native form of matrix protein 2 of influenza A viruses. , 2011, Journal of immunological methods.
[4] W. Zeng,et al. A Modular Approach to Assembly of Totally Synthetic Self-adjuvanting Lipopeptide-based Vaccines Allows Conformational Epitope Building* , 2011, The Journal of Biological Chemistry.
[5] R. Compans,et al. Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus , 2010, Proceedings of the National Academy of Sciences.
[6] S. Epstein,et al. Cross-protective immunity to influenza A viruses , 2010, Expert review of vaccines.
[7] S. Rockman,et al. A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody , 2010, Immunology and cell biology.
[8] W. Fiers,et al. M2e-based universal influenza A vaccine. , 2009, Vaccine.
[9] W. Fiers,et al. Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments , 2009, Expert review of vaccines.
[10] J. Shiver,et al. Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus. , 2009, Virology.
[11] J. Shiver,et al. Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys. , 2009, Vaccine.
[12] J. Wade,et al. Synthesis, Conformation, and Activity of Human Insulin-Like Peptide 5 (INSL5) , 2008, Chembiochem : a European journal of chemical biology.
[13] W. Fiers,et al. An Influenza A Vaccine Based on Tetrameric Ectodomain of Matrix Protein 2* , 2008, Journal of Biological Chemistry.
[14] Ying-hua Chen,et al. Characterization of immunity induced by M2e of influenza virus. , 2007, Vaccine.
[15] L. Otvos,et al. Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse , 2007, Virology Journal.
[16] J. Wade,et al. Improved chemical synthesis and demonstration of the relaxin receptor binding affinity and biological activity of mouse relaxin. , 2007, Biochemistry.
[17] Barbara Imperiali,et al. Protein oligomerization: how and why. , 2005, Bioorganic & medicinal chemistry.
[18] J. Shiver,et al. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. , 2004, Vaccine.
[19] W. Fiers,et al. A "universal" human influenza A vaccine. , 2004, Virus research.
[20] A. Jegerlehner,et al. Influenza A Vaccine Based on the Extracellular Domain of M2: Weak Protection Mediated via Antibody-Dependent NK Cell Activity , 2004, The Journal of Immunology.
[21] L. Otvos,et al. Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. , 2003, Vaccine.
[22] Walter Fiers,et al. A universal influenza A vaccine based on the extracellular domain of the M2 protein , 1999, Nature Medicine.
[23] R. Lamb,et al. The active oligomeric state of the minimalistic influenza virus M2 ion channel is a tetramer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[24] A. Hay,et al. Structural characteristics of the M2 protein of influenza a viruses: Evidence that it forms a tetrameric channe , 1991, Virology.
[25] V. Nussenzweig,et al. Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria , 1990, The Journal of experimental medicine.
[26] R. Lamb,et al. Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface , 1985, Cell.
[27] R. Lamb,et al. Identification of a second protein (M2) encoded by RNA segment 7 of influenza virus. , 1981, Virology.
[28] W. Kowalczyk,et al. Strategies and limitations in dendrimeric immunogen synthesis. The influenza virus M2e epitope as a case study. , 2010, Bioconjugate chemistry.